PLATINUM-RESISTANT HIGH GRADE SEROUS PRIMARY PERITONEAL CANCER
Clinical trials for PLATINUM-RESISTANT HIGH GRADE SEROUS PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT HIGH GRADE SEROUS PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT HIGH GRADE SEROUS PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug azenosertib takes on Chemo-Resistant ovarian cancer in phase 3 trial
Disease control Recruiting nowThis phase 3 study tests whether a new drug called azenosertib works better than standard chemotherapy for people with a specific type of ovarian cancer that no longer responds to platinum-based treatments. The trial enrolls 420 women whose tumors have a high level of a protein c…
Matched conditions: PLATINUM-RESISTANT HIGH GRADE SEROUS PRIMARY PERITONEAL CANCER
Phase: PHASE3 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer?
Disease control Recruiting nowThis early-stage trial tests an investigational drug called ABBV-901, alone or with a standard drug bevacizumab, in about 219 adults with advanced ovarian cancer that no longer responds to platinum chemotherapy. The main goals are to check safety and see if the drug can shrink tu…
Matched conditions: PLATINUM-RESISTANT HIGH GRADE SEROUS PRIMARY PERITONEAL CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC